2017
DOI: 10.1194/jlr.m072280
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetic control of microsomal prostaglandin E synthase-1 by HDAC-mediated recruitment of p300

Abstract: Nonsteroidal anti-inflammatory drugs are the most widely used medicine to treat pain and inflammation, and to inhibit platelet function. Understanding the expression regulation of enzymes of the prostanoid pathway is of great medical relevance. Histone acetylation crucially controls gene expression. We set out to identify the impact of histone deacetylases (HDACs) on the generation of prostanoids and examine the consequences on vascular function. HDAC inhibition (HDACi) with the pan-HDAC inhibitor, vorinostat,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…A number of HDAC inhibitors have been tested in different pain models and it has been shown that they have analgesic effects through different mechanisms ( Chiechio et al, 2009 , 2010 ; Bai et al, 2010 ; Zhang et al, 2011 ; Denk et al, 2013 ; Matsushita et al, 2013 ; Onofrj et al, 2013 ; Ximenes et al, 2013 ; Chen et al, 2014 ; Kukkar et al, 2014 ; Zammataro et al, 2014 ; Capasso et al, 2015 ; Cao et al, 2016 ; Tao et al, 2016 ; Alqinyah et al, 2017 ; Fork et al, 2017 ; Lin et al, 2017 ). We first demonstrated that HDAC inhibitors have analgesic properties via the upregulation of the metabotropic glutamate receptor type-2 ( Chiechio et al, 2009 , 2010 ; Onofrj et al, 2013 ), an inhibitory receptor whose activation or upregulation mediates analgesia ( Chiechio et al, 2002 , 2009 , 2010 ; Onofrj et al, 2013 ; Zammataro et al, 2014 ; Chiechio, 2016 ).…”
Section: Discussionmentioning
confidence: 99%
“…A number of HDAC inhibitors have been tested in different pain models and it has been shown that they have analgesic effects through different mechanisms ( Chiechio et al, 2009 , 2010 ; Bai et al, 2010 ; Zhang et al, 2011 ; Denk et al, 2013 ; Matsushita et al, 2013 ; Onofrj et al, 2013 ; Ximenes et al, 2013 ; Chen et al, 2014 ; Kukkar et al, 2014 ; Zammataro et al, 2014 ; Capasso et al, 2015 ; Cao et al, 2016 ; Tao et al, 2016 ; Alqinyah et al, 2017 ; Fork et al, 2017 ; Lin et al, 2017 ). We first demonstrated that HDAC inhibitors have analgesic properties via the upregulation of the metabotropic glutamate receptor type-2 ( Chiechio et al, 2009 , 2010 ; Onofrj et al, 2013 ), an inhibitory receptor whose activation or upregulation mediates analgesia ( Chiechio et al, 2002 , 2009 , 2010 ; Onofrj et al, 2013 ; Zammataro et al, 2014 ; Chiechio, 2016 ).…”
Section: Discussionmentioning
confidence: 99%
“…When NPY is expressed in large quantities, it will participate in pain nerve transmission (18). High expression of PGE2 will reduce the pain threshold of patients and increase their subjective pain (19). 5-HT can centrally transmission pain signals through the cerebral cortex to produce pain (20).…”
Section: Discussionmentioning
confidence: 99%